Sponsors

Calprotectin and elastase: update on faecal testing for gastrointestinal diseases

Screening of faecal samples for blood and microorganisms is commonplace, yet testing that can distinguish irritable from inflammatory bowel conditions, and detect pancreatic exocrine insufficiency. is equally important, as this review illustrates.

Gastrointestinal disease, including conditions such as inflammatory bowel disease (IBD; most commonly Crohn’s disease and ulcerative colitis), irritable bowel syndrome (IBS), coeliac disease and food allergy, is a significant healthcare burden on the NHS. Gastrointestinal symptoms are one of the most common complaints patients present with and frequently these symptoms are representative of several gastrointestinal diseases, making it difficult to diagnose on a clinical history alone.

In terms of symptoms, IBS and IBD are the two gastrointestinal diseases that are most similar. Common symptoms include abdominal pain, chronic diarrhoea, bloating, anaemia, fatigue and depression. However, IBS and IBD are somewhat different in terms of pathology, treatment options, prevalence, prognosis and quality of life.

               

Log in or register FREE to read the rest

This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text. If you don't already have an account, please register with us completely free of charge.

Latest Issues

Association for Molecular Pathology (AMP) 2024 Annual Meeting & Expo

Hyatt Regency, Vancouver, Canada
19-23 November, 2024

11th Digital Pathology & AI Congress: Europe

Hilton London Metropole, 255 Edgware Road, London, W2 1JU
11-12 December, 2024

Microbiology Society Annual Conference 2025

Liverpool Arena and Convention Centre
31 March - 3 April, 2025

BSMT Annual Microbiology Conference

RAF Museum, Hendon, London NW9 5LL
15 May, 2025

Ghent Pathology 2025

ICC Ghent, Belgium
24-26 June, 2025